BRPI0520564A2 - método de tratar doença pulmonar com interferons apoio governamental - Google Patents

método de tratar doença pulmonar com interferons apoio governamental

Info

Publication number
BRPI0520564A2
BRPI0520564A2 BRPI0520564-6A BRPI0520564A BRPI0520564A2 BR PI0520564 A2 BRPI0520564 A2 BR PI0520564A2 BR PI0520564 A BRPI0520564 A BR PI0520564A BR PI0520564 A2 BRPI0520564 A2 BR PI0520564A2
Authority
BR
Brazil
Prior art keywords
interferons
interferon
government support
pulmonary disease
treating pulmonary
Prior art date
Application number
BRPI0520564-6A
Other languages
English (en)
Inventor
Rany Condos
Gerald C Smaldone
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of BRPI0520564A2 publication Critical patent/BRPI0520564A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MéTODO DE TRATAR DOENçA PULMONAR COM INTERFERONS APOIO GOVERNAMENTAL. Um método de tratar uma doença pulmonar tal como, por exempio, fibrose pulmonar idiopática (IPF) e asma, que compreende administrar um interferon aerossolizado tal como interferon Cx, interferon ç3 ou interferon y em uma quantidade terapeuticamente eficaz é fornecido aqui. Ainda, composições farmacêuticas de um ou mais interferon(s) aerossolizados são fornecidas.
BRPI0520564-6A 2005-09-20 2005-09-20 método de tratar doença pulmonar com interferons apoio governamental BRPI0520564A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/033747 WO2007035180A1 (en) 2005-09-20 2005-09-20 Method of treating pulmonary disease with interferons

Publications (1)

Publication Number Publication Date
BRPI0520564A2 true BRPI0520564A2 (pt) 2009-05-19

Family

ID=37889126

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520564-6A BRPI0520564A2 (pt) 2005-09-20 2005-09-20 método de tratar doença pulmonar com interferons apoio governamental

Country Status (8)

Country Link
EP (2) EP2494982B1 (pt)
JP (1) JP5175198B2 (pt)
KR (1) KR20130110225A (pt)
CN (1) CN101378774A (pt)
AU (1) AU2005336519B2 (pt)
BR (1) BRPI0520564A2 (pt)
CA (1) CA2622987C (pt)
WO (1) WO2007035180A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343081A1 (en) * 2009-12-31 2011-07-13 Rijksuniversiteit Groningen Interferon analogs
US20210212988A1 (en) * 2018-05-17 2021-07-15 Actuate Therapeutics Inc. Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form beta inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
JPH05500229A (ja) * 1991-04-12 1993-01-21 東レ株式会社 固体ポリペプチド微粒子のエアロゾル製剤とその製造方法
US6030609A (en) * 1995-05-19 2000-02-29 Case Western Reserve University Method and composition for treating paramyxovirus
US20010043906A1 (en) * 1999-12-30 2001-11-22 Vlasselaer Peter Van gamma-IFN liquid-droplet aerosol and method
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6964761B1 (en) * 2001-12-12 2005-11-15 New York University Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
JP2006502153A (ja) * 2002-08-27 2006-01-19 インターミューン インコーポレイティッド 特発性肺線維症の治療方法
WO2004112691A2 (en) * 2003-05-19 2004-12-29 Intermune, Inc. Interferon gamma therapies for idiopathic pulmonary fibrosis
GB0405634D0 (en) 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases

Also Published As

Publication number Publication date
CN101378774A (zh) 2009-03-04
EP1940451A4 (en) 2010-03-17
EP2494982A1 (en) 2012-09-05
AU2005336519B2 (en) 2012-05-10
JP5175198B2 (ja) 2013-04-03
EP2494982B1 (en) 2016-10-26
WO2007035180A1 (en) 2007-03-29
JP2009508947A (ja) 2009-03-05
CA2622987A1 (en) 2007-03-29
AU2005336519A1 (en) 2007-03-29
CA2622987C (en) 2018-02-27
KR20130110225A (ko) 2013-10-08
EP1940451A1 (en) 2008-07-09

Similar Documents

Publication Publication Date Title
AU2018256602A1 (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
CY1116285T1 (el) Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα
BRPI0815395A2 (pt) Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
BRPI0414425A (pt) composições farmacêuticas
CL2007001283A1 (es) Compuestos derivados de pirazinona
BRPI0513283A (pt) combinações de estatina com broncodilatadores
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
BRPI0518476A2 (pt) compostos e derivados de dibenzil amina
MX2008010222A (es) Antibioticos nebulizados para terapia de inhalacion.
PE20060078A1 (es) Compuesto pirazolo [3,4-b]piridina como inhibidor de fosfodiesterasa tipo iv
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
ATE485304T1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
CL2008002411A1 (es) Compuestos derivados de heterociclos de nitrogenos;composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la miosina del musculo liso o la miosina no muscular, tales como hipertension, enfermedad pulmonar, glaucoma, apoplejia, enfermedades broncocontrictoras, entre otras.
EA200970487A1 (ru) Применение пролекарств аналогов гамк для лечения заболеваний
CL2007003765A1 (es) Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias.
DE112007003185A5 (de) Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
CL2007002274A1 (es) Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras.
BRPI0313764A2 (pt) método de preparação de composições de inalação de pó seco
SG10201501376XA (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
WO2008103378A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
WO2008052173A8 (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
BRPI0520564A2 (pt) método de tratar doença pulmonar com interferons apoio governamental
EA200800181A1 (ru) Фармацевтическая композиция glp-1
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL